<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Biotalys Nv — News on 6ix</title>
    <link>https://6ix.com/company/biotalys-nv-1</link>
    <description>Latest news and press releases for Biotalys Nv on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 06 May 2026 05:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/biotalys-nv-1" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d68d3fbeedb30cb6fef281.webp</url>
      <title>Biotalys Nv</title>
      <link>https://6ix.com/company/biotalys-nv-1</link>
    </image>
    <item>
      <title>Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-obtains-subscription-commitments-for-eur-1205-million-through-a-private-placement-of-new-shares-with-current-investors-2</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-obtains-subscription-commitments-for-eur-1205-million-through-a-private-placement-of-new-shares-with-current-investors-2</guid>
      <pubDate>Wed, 06 May 2026 05:00:00 GMT</pubDate>
      <description>Press release – regulated information – inside informationGhent, BELGIUM, May 06, 2026 (GLOBE NEWSWIRE) -- Public announcement in accordance with article 7:97,§4/1 of the Belgian Companies and Associations Code Biotalys (Euronext: BTLS) (the “Company” or “Biotalys”), today announced it has successfully obtained subscription commitments for new shares for an amount of EUR 12,050,000 through a private placement (“Private Placement”). The Private Placement involves the issue of 7,875,811 new shares</description>
    </item>
    <item>
      <title>Biotalys Reports Full-Year 2025 Financial Results and Business Highlights</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-reports-full-year-2025-financial-results-and-business-highlights</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-reports-full-year-2025-financial-results-and-business-highlights</guid>
      <pubDate>Wed, 29 Apr 2026 05:00:00 GMT</pubDate>
      <description>Regulated informationGhent, BELGIUM, April 29, 2026 (GLOBE NEWSWIRE) -- Earned final approval by the U.S. EPA and positive recommendation by the Dutch regulator for its first candidate biofungicide EVOCA™, paving the path for its commercial version EVOCA NG Streamlined leadership and operations to concentrate resources on commercial preparation of EVOCA NG and BioFun-6 in high-value markets Year-end cash and cash equivalents amounted to €8.0 million, providing a financial runway until end of May</description>
    </item>
    <item>
      <title>Biotalys Achieves First U.S. State Registration for EVOCA in Florida</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-achieves-first-us-state-registration-for-evoca-in-florida-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-achieves-first-us-state-registration-for-evoca-in-florida-1</guid>
      <pubDate>Mon, 27 Apr 2026 05:00:00 GMT</pubDate>
      <description>Regulatory Process also Advancing in Key Markets California and EuropeGhent, BELGIUM, April 27, 2026 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext: BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, today announced that its innovative biofungicide EVOCA™ has achieved state registration in Florida. This marks the first approval of an AGROBODY™ biocontrol by a U.S. state, underscoring a significant milestone for the compa</description>
    </item>
    <item>
      <title>Biotalys Achieves First Milestone in Bioinsecticide Partnership with Syngenta</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-achieves-first-milestone-in-bioinsecticide-partnership-with-syngenta-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-achieves-first-milestone-in-bioinsecticide-partnership-with-syngenta-1</guid>
      <pubDate>Tue, 07 Apr 2026 05:00:00 GMT</pubDate>
      <description>Successful initial tests in research for novel AGROBODY™ bioactive against key insect pestGhent, BELGIUM, April 07, 2026 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext: BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announced it has achieved a first research milestone in its partnership with Syngenta, a global leader in agricultural innovation, to develop a novel bioinsecticide against key insect pests</description>
    </item>
    <item>
      <title>Biotalys Announces New Dates for the Publication of its 2025 Annual Report and for its Annual Shareholders Meeting</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-announces-new-dates-for-the-publication-of-its-2025-annual-report-and-for-its-annual-shareholders-meeting</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-announces-new-dates-for-the-publication-of-its-2025-annual-report-and-for-its-annual-shareholders-meeting</guid>
      <pubDate>Tue, 24 Mar 2026 06:00:00 GMT</pubDate>
      <description>Update on the further financing of the companyGhent, BELGIUM, March 24, 2026 (GLOBE NEWSWIRE) -- Press release – regulated information Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announces that it will publish its annual report and financial results for the full year of 2025 on Wednesday, 29 April 2026 at 07:00 CEST. This new date allows the company to take the recently announced chan</description>
    </item>
    <item>
      <title>Biotalys Announces Changes to its Board of Directors and Executive Committee</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-announces-changes-to-its-board-of-directors-and-executive-committee</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-announces-changes-to-its-board-of-directors-and-executive-committee</guid>
      <pubDate>Tue, 17 Mar 2026 06:00:00 GMT</pubDate>
      <description>Regulated information - Inside information*Ghent, BELGIUM, March 17, 2026 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announced changes to its board and management team. As a result of the changes announced today, the Board of Directors will be reduced from eight members to six and the Executive Committee from four to two. Board member Laura Meyer will step down wi</description>
    </item>
    <item>
      <title>Biotalys Notice of Publication 2025 Annual Report and Financial Results</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-notice-of-publication-2025-annual-report-and-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-notice-of-publication-2025-annual-report-and-financial-results</guid>
      <pubDate>Tue, 24 Feb 2026 17:00:00 GMT</pubDate>
      <description>Webcast and Conference Call to take place on Friday, 27 March 2026 at 15:00 CET / 14:00 GMT / 09:00 AM ETGhent, BELGIUM, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announces that it will publish its annual report and consolidated financial results for the full year of 2025 on Friday, 27 March 2026 at 07:00 CET. Webcast and Conference Ca</description>
    </item>
    <item>
      <title>Biotalys Announces Intention to Strategically Refocus its Activities to Prioritize Lead Assets and Reduce Annual Cash Burn</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-announces-intention-to-strategically-refocus-its-activities-to-prioritize-lead-assets-and-reduce-annual-cash-burn-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-announces-intention-to-strategically-refocus-its-activities-to-prioritize-lead-assets-and-reduce-annual-cash-burn-1</guid>
      <pubDate>Mon, 09 Feb 2026 11:00:00 GMT</pubDate>
      <description>Inside informationGhent, BELGIUM, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Biotalys (Euronext: BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, today announced its intention to proceed with a strategic refocus designed to concentrate resources on its highest-priority programs and streamline operations accordingly. As part of this initiative, Biotalys intends to right-size its organizational structure and suspend its early-stage act</description>
    </item>
    <item>
      <title>Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-and-21stbio-enter-into-strategic-partnership-to-advance-biocontrol-production-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-and-21stbio-enter-into-strategic-partnership-to-advance-biocontrol-production-1</guid>
      <pubDate>Fri, 23 Jan 2026 06:00:00 GMT</pubDate>
      <description>Biotalys Provides Update on Its Plans to Fund Next Phase of DevelopmentGhent, BELGIUM, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Press release – inside information* Biotalys (Euronext: BTLS) and 21st.BIO, a leading Danish precision fermentation technology company, have entered into a strategic partnership to accelerate the production of Biotalys’ protein-based biocontrol solutions. This collaboration will leverage 21st.BIO’s proprietary fermentation platform to support the production of Biotalys’ AGROBO</description>
    </item>
    <item>
      <title>Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-receives-regulatory-approval-by-us-epa-for-evoca-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-receives-regulatory-approval-by-us-epa-for-evoca-1</guid>
      <pubDate>Tue, 02 Dec 2025 06:00:00 GMT</pubDate>
      <description>U.S. Registration Marks a Significant Milestone as the First Protein-Based Biofungicide of its Kind to be Approved by the EPAGhent, BELGIUM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Press release - inside information Biotalys (Euronext: BTLS) is excited to announce it has received regulatory approval from the U.S. Environmental Protection Agency (EPA) for its first biofungicide, EVOCA™*. This product was developed using Biotalys’ AGROBODY™ technology platform and is the first protein-based biofungicide</description>
    </item>
    <item>
      <title>EPA Issues Proposed Registration Decision for Biotalys’ EVOCA™ Biofungicide</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/epa-issues-proposed-registration-decision-for-biotalys-evocatm-biofungicide-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/epa-issues-proposed-registration-decision-for-biotalys-evocatm-biofungicide-1</guid>
      <pubDate>Fri, 31 Oct 2025 06:00:00 GMT</pubDate>
      <description>U.S. Environmental Protection Agency Initiates Public Participation ProcedureGhent, Belgium, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Press release – inside information EPA Issues Proposed Registration Decision for Biotalys’ EVOCA™ Biofungicide U.S. Environmental Protection Agency Initiates Public Participation Procedure Ghent, BELGIUM – October 31, 2025, 7.00 CET – Biotalys (Euronext: BTLS) is pleased to announce that the United States Environmental Protection Agency (EPA) has issued its proposed regi</description>
    </item>
    <item>
      <title>Regulated information</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/regulated-information-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/regulated-information-1</guid>
      <pubDate>Mon, 20 Oct 2025 16:00:00 GMT</pubDate>
      <description>Information on the total number of voting rights and sharesGhent, Belgium, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Biotalys NV (hereafter the “Company” or “Biotalys”) today announces, in accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings (the “Belgian Act”), that the outstanding share capital and outstanding voting securities of the Company can be summarised as follows: Share capital: EUR 5,555,181.05 EURTotal number of securities carrying voting right</description>
    </item>
    <item>
      <title>Biotalys Reports Half-Year 2025 Financial Results and Business Highlights</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-reports-half-year-2025-financial-results-and-business-highlights-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-reports-half-year-2025-financial-results-and-business-highlights-1</guid>
      <pubDate>Thu, 18 Sep 2025 05:00:00 GMT</pubDate>
      <description>Press release - regulated informationGhent, Belgium, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Substantial progress in both the U.S. and Europe in the regulatory review of Biotalys’ first candidate biofungicide EVOCA™*Patent protection for EVOCA in Brazil and China, and for a BioFun-6 lead candidate in the U.S.Strategic partnership with AgroFresh to expand into post-harvest segmentLeadership team expanded with proven industry executives Cash and cash equivalents amounted to €15.7 million as of the end</description>
    </item>
    <item>
      <title>Biotalys Provides Regulatory Review Update for EVOCA in the U.S.</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-provides-regulatory-review-update-for-evoca-in-the-us-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-provides-regulatory-review-update-for-evoca-in-the-us-1</guid>
      <pubDate>Fri, 29 Aug 2025 05:00:00 GMT</pubDate>
      <description>Inside informationGhent, BELGIUM, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS) today provides an update on the regulatory approval procedure in the United States of its first protein-based biocontrol product, EVOCA™*. Biotalys has received further guidance from the U.S. Environmental Protection Agency (EPA) on the regulatory review of EVOCA. The EPA has confirmed that the scientific review of the dossier is progressing, and that all the requests for additional information have be</description>
    </item>
    <item>
      <title>Information on the total number of voting rights and shares</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/information-on-the-total-number-of-voting-rights-and-shares-2</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/information-on-the-total-number-of-voting-rights-and-shares-2</guid>
      <pubDate>Wed, 30 Jul 2025 16:00:00 GMT</pubDate>
      <description>Press Release - Regulated InformationGhent, BELGIUM, July 30, 2025 (GLOBE NEWSWIRE) -- Biotalys NV (hereafter the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for crop protection, today announces in accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings (the “Belgian Act”) that the outstanding share capital and outstanding voting securities of the Company can be summarised as foll</description>
    </item>
    <item>
      <title>Publication of transparency notification</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/publication-of-transparency-notification-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/publication-of-transparency-notification-1</guid>
      <pubDate>Mon, 16 Jun 2025 16:00:00 GMT</pubDate>
      <description>Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares are admitted to trading on a regulated marketGhent, BELGIUM, June 16, 2025 (GLOBE NEWSWIRE) -- Press release - regulated information Biotalys NV (Euronext Brussel : BTLS) (the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, announces today, in accordance with article 14 of the Act of 2 May 2007</description>
    </item>
    <item>
      <title>Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-reports-progress-in-the-regulatory-review-of-evoca-in-both-us-and-eu-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-reports-progress-in-the-regulatory-review-of-evoca-in-both-us-and-eu-1</guid>
      <pubDate>Wed, 11 Jun 2025 05:00:00 GMT</pubDate>
      <description>US EPA projects taking a regulatory decision by end of September 2025; Dutch authorities finalise first phase of regulatory dossier for EVOCA in EuropeGhent, BELGIUM, June 11, 2025 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, is pleased to announce progress in the regulatory approval procedures in both the United States and Europe of its first protein-based biocontro</description>
    </item>
    <item>
      <title>Biotalys Appoints Luc Van fraeyenhoven as Chief Financial Officer</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-appoints-luc-van-fraeyenhoven-as-chief-financial-officer-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-appoints-luc-van-fraeyenhoven-as-chief-financial-officer-1</guid>
      <pubDate>Mon, 26 May 2025 05:00:00 GMT</pubDate>
      <description>Seasoned Financial Executive Will Lead Finance Operations as Biotalys Pushes Product Pipeline Toward CommercializationGhent, May 26, 2025 (GLOBE NEWSWIRE) -- Press release Ghent, BELGIUM – 26 May 2025, 07:00 CEST – Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, today announced the appointment of Luc Van fraeyenhoven as Chief Financial Officer (CFO). He succeeds Douglas Minder, who will pursue other car</description>
    </item>
    <item>
      <title>Biotalys and AgroFresh Partner to Protect Fresh Produce</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/biotalys-and-agrofresh-partner-to-protect-fresh-produce-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/biotalys-and-agrofresh-partner-to-protect-fresh-produce-1</guid>
      <pubDate>Tue, 20 May 2025 05:00:00 GMT</pubDate>
      <description>Global leaders in sustainable agricultural innovation to develop biological solutions to reduce food wasteGhent, BELGIUM, and Philadelphia, USA, May 20, 2025 (GLOBE NEWSWIRE) -- Press release Ghent, BELGIUM, and Philadelphia, USA – 20 May 2025, 07.00 CEST – An estimated 14 percent of produce is lost between harvest and retail*, in part due to spoilage from mold and rot. To help address this global challenge, Biotalys (Euronext - BTLS), an agricultural technology (AgTech) company developing prote</description>
    </item>
    <item>
      <title>Results of the Ordinary Shareholders’ Meeting</title>
      <link>https://6ix.com/company/biotalys-nv-1/news/results-of-the-ordinary-shareholders-meeting-1</link>
      <guid isPermaLink="true">https://6ix.com/company/biotalys-nv-1/news/results-of-the-ordinary-shareholders-meeting-1</guid>
      <pubDate>Tue, 22 Apr 2025 16:00:00 GMT</pubDate>
      <description>Regulated InformationGhent, Belgium, April 22, 2025 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS) (the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, held its ordinary shareholders&apos; meeting today at 10:00 CEST at the Company’s seat. The shareholders approved all items on the agenda of the meetings. All documents relating to the shareholders’ meetings can be consulted on the website of the Company. The m</description>
    </item>
  </channel>
</rss>